Grantham, Mayo, Van Otterloo & Co (GMO)’s Linde LIN Stock Holding History

Grantham, Mayo, Van Otterloo & Co (GMO)’s Portfolio LIN Stock Details LIN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-2,626	Closed	-$1.12M	–	682
2025 Q4	$1.12M	Hold	2,626	–	–	﹤0.01%	504
2025 Q3	$1.25M	Buy	2,626 +91	+4%	+$43.1K	﹤0.01%	443
2025 Q2	$1.19M	Sell	2,535 -84	-3%	-$38.3K	﹤0.01%	444
2025 Q1	$1.22M	Sell	2,619 -156	-6%	-$70.2K	﹤0.01%	423
2024 Q4	$1.16M	Buy	2,775 +249	+10%	+$113K	﹤0.01%	430
2024 Q3	$1.2M	Buy	+2,526	New	+$1.15M	﹤0.01%	416
2021 Q2	–	Sell	-2,346	Closed	-$657K	–	797
2021 Q1	$657K	Buy	+2,346	New	+$609K	﹤0.01%	656

Other funds holding LIN

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Grantham, Mayo, Van Otterloo & Co (GMO)'s LIN Position: Q1 2026 in Review

Grantham, Mayo, Van Otterloo & Co (GMO) sold out of Linde (LIN) in Q1 2026, closing a stake of 2,626 shares — an estimated $1.12M sold.

Grantham, Mayo, Van Otterloo & Co (GMO) first reported a position in LIN in Q1 2021 and held it in 7 quarters. The position peaked at $1.25M in Q3 2025. 2,267 funds tracked by Wall St. Rank hold LIN as of Q1 2026.

Grantham, Mayo, Van Otterloo & Co (GMO) reported no remaining Linde position as of Q1 2026 after selling out during the quarter.
Grantham, Mayo, Van Otterloo & Co (GMO) sold 2,626 Linde shares in Q1 2026, an estimated $1.12M.
Grantham, Mayo, Van Otterloo & Co (GMO) first reported a position in Linde in Q1 2021 and held it in 7 quarters.
Grantham, Mayo, Van Otterloo & Co (GMO)'s Linde position peaked at $1.25M in Q3 2025.
2,267 funds tracked by Wall St. Rank held Linde as of Q1 2026.

Based on Grantham, Mayo, Van Otterloo & Co (GMO)'s 13F filing for Q1 2026, filed 14 May 2026.